A phase i single-arm, multicenter pilot study aimed at validating y-ohpdg as a biomarker and testing the effects of polyphenon e on its levels in patients with cirrhosis

Ended Awarded Last action

Contract number
HHSN26100013
Awardee
Awarding agency
Obligated
$789,841

Award facts

Contract value 56% obligated
  • $789,840.52 Current, with exercised options
  • $1,398,567.52 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Evanston, IL 60208, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · FY26 UDO initiative; a phase i single-arm, multicenter pilot study aimed at validating y-ohpdg as a biomarker and testing the effects of polyphenon e on its… -$12,115
Funding Only Action P00006 -$128,400
Exercise an Option P00005 $142,069
Change Order P00004 $0
Exercise an Option P00003 $142,069
Exercise an Option P00002 $225,212
Change Order P00001 -$29,098
Original award $450,103

About this award

The National Cancer Institute issued a delivery order to Northwestern University on September 15, 2017, under the Cancer Prevention Agent Development Program 2012-2017 parent vehicle, for a Phase I single-arm multicenter pilot study validating Y-OHPDG as a biomarker and testing polyphenon E effects in cirrhosis patients. The order carries a ceiling value of $1,398,567.52 on a cost-no-fee basis.

Place of performance is Evanston, IL. Ultimate completion was September 22, 2023.

Service Contract Inventory data shows declining labor footprint: FY2021 invoiced $76 thousand across 1.5 FTEs and 3,047 contractor hours at a derived rate of $24.90 per hour; FY2022 invoiced $216 thousand across 0.4 FTEs and 942 contractor hours at $229.29 per hour. By FY2022, 100 percent of contractor hours were subcontracted, with 2 subcontractors reported.

Quick answers

Who was awarded contract HHSN26100013?

HHSN26100013 was awarded to Northwestern University by National Cancer Institute (National Institutes of Health) on September 15, 2017.

How much is contract HHSN26100013 worth?

The government has obligated $789,841 on HHSN26100013. Its potential value, with all options, is $1,398,568.

Is contract HHSN26100013 an order under another contract?

Yes. HHSN26100013 is a delivery order under HHSN261201200035I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100013 competed?

The extent of competition for HHSN26100013 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award